BBlogFlow

Give me the good news: four science stories to brighten your day - Nature

·2d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

A new species of sea spider, Tanystylum kiixin, has been discovered. Credit: Cormac Toler-ScottAmid wars, AI doom and a super El Niño, good news can seem in short supply. But it is there if you go looking. In Nature’s latest collection of stories selected to bring readers joy, learn about a country that has reversed its rates of diabetes and umbrella that keep corals cool. But first, you might have heard about reports of the first new wild cat species in a century, announced last month1. The spotted feline, called Leopardus tilcayo, was found in the forested Yungas region of Bolivia. The news is not all bad: five inspiring science stories to lift your moodBut did you know that a new member has also been inducted into the penguin family this year? A population of penguins on the remote Kerguelen Islands — around 2,000 kilometres north of Antarctica in the Indian Ocean — has been designated as a new species, the southeastern gentoo (Pygoscelis kerguelensis)2. This addresses a long-running debate about whether the gentoo penguin (Pygoscelis papua) is one species or several.

This article is an excerpt. To read the full content, visit the original source. Nature

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·